Andrew K. Balo

Insider Reports History

Location
San Diego, CA
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew K. Balo:

Company Role Class Num Shares Value Price $ Report Date Ownership
DEXCOM INC EVP Regulatory Strategy Clinic Common Stock 50,908 $6,294,000 $123.63 10 Mar 2023 Direct
DEXCOM INC EVP Regulatory Strategy Clinic Common Stock 30,212 $3,735,255 $123.63 10 Mar 2023 by Trust
Glucotrack, Inc. Director Common Stock, par value $0.001 per share 4,692 $22,850 $4.87 03 Oct 2025 Direct
Glucotrack, Inc. Director Stock option (right to buy) 4,055 03 Oct 2025 Direct

Insider Reports Filed by Andrew K. Balo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GCTK Glucotrack, Inc. 26 Mar 2025 1 $0 4 Director 28 Mar 2025, 20:57
GCTK Glucotrack, Inc. 25 Mar 2025 4 $0 4 Director 07 Oct 2025, 21:38
GCTK Glucotrack, Inc. 14 Jun 2024 0 $0 3 Director 28 Mar 2025, 20:21
DXCM DEXCOM INC 10 Mar 2023 3 -$1,300,026 4 EVP Regulatory Strategy Clinic 14 Mar 2023, 16:45
DXCM DEXCOM INC 08 Mar 2022 4 -$1,392,769 4 EVP, Global Medical Affairs 10 Mar 2022, 18:22
DXCM DEXCOM INC 09 Sep 2021 12 -$3,060,337 4 Officer 13 Sep 2021, 20:19
DXCM DEXCOM INC 03 Aug 2021 8 -$1,422,247 4 Officer 04 Aug 2021, 20:36
DXCM DEXCOM INC 06 Jul 2021 4 -$1,279,228 4 Officer 08 Jul 2021, 19:45
DXCM DEXCOM INC 03 Jun 2021 3 -$896,625 4 Officer 07 Jun 2021, 19:33